Calcium‑sensing Receptor Polymorphisms at rs1801725 and High Circulating Calcium in Breast Cancer: Possible Molecular Explanation

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(S 01): S191
DOI: 10.4103/ijmpo.ijmpo_195_17

Letter to Editor

Pathum Sookaromdee

TWS Medical Center, Bangkok, Thailand

,

Viroj Wiwanitkit

Department of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China

Department of Community Medicine, Dr. D. Y. Patil University, Pune, Maharashtra, India

Department of Medical Science, Faculty of Medicine, University of Niš, Niš, Serbia

Department of Biological Science, Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, Nigeria

References
1 Shao T, Klein P, Grossbard ML. Vitamin D and breast cancer. Oncologist 2012; 17: 36-45
2 Sprague BL, Skinner HG, Trentham-Dietz A, Lee KE, Klein BE, Klein R. et al. Serum calcium and breast cancer risk in a prospective cohort study. Ann Epidemiol 2010; 20: 82-5
3 Wang L, Widatalla SE, Whalen DS, Ochieng J, Sakwe AM. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients. BMC Cancer 2017; 17: 511
4 Joob B, Wiwanitkit V. HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: Quantum chemical analysis and implication in patients with renal transplantation. J Nephropharmacol 2017; 6: 19-20